Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0015672 (
fatigue
)
51,768
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A cross-sectional study was conducted among 249 Chinese cancer patients with multiple diagnoses to validate a Chinese version of the Brief
Fatigue
Inventory (BFI-C). Cronbach's coefficient alpha was 0.92 for
fatigue
severity items and 0.90 for
fatigue
interference items. Construct validity was explored by principal factor analysis and suggested a two-factor solution:
fatigue
severity and
fatigue
interference. Internal consistency reliability was excellent. Convergent validity was examined by correlating the BFI-C with 2 subscales and 2 component scores of the
MOS
36-Item Short-Form Health Survey (coefficients ranged between -0.44 and -0.71, P<0.001). Known-group validity was examined by comparing
fatigue
severity in patients having different scores on the Eastern Cooperative Oncology Group Performance Status Scale. Approximately 60% of patients experienced moderate to severe
fatigue
(4 or greater on the 0-10 scale of the BFI-C "fatigue worst" item). The BFI-C is a valid, reliable instrument to measure the severity and impact of cancer-related
fatigue
among Chinese patients.
...
PMID:Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). 1505 Jun 60
In addition to chronic hepatitis, many individuals infected with hepatitis C virus (HCV) suffer from
fatigue
, which may compromise their health-related quality of life (HRQL). To assess systematically health-related quality of life (HRQL) in patients with chronic hepatitis C and to determine if any clinical, biochemical, virologic, demographic, and histologic features are associated with HRQL status. In this cross-sectional observational study, one hundred thirty patients with chronic HCV infection (HCV RNA positive by PCR) and 61 healthy controls were enrolled from a tertiary care teaching medical center. All patients and controls completed one generic HRQL questionnaire (
MOS
SF-36) and one liver-disease specific instrument (Chronic Liver Disease Questionnaire, CLDQ). Ninety-five HCV patients and all the controls also completed a
fatigue
questionnaire (Chronic
Fatigue
Screener, CFS) and had immunologic markers determined (Cryoglobulin, Soluble IL-2 receptors, Rheumatoid Factor). We compared the HRQL of HCV-infected patients to the controls and, using data from other studies, to the general population, patients with diabetes, and patients with chronic low back pain. Patients with chronic HCV had greater HRQL impairment than healthy controls and those with type II diabetes.
Fatigue
was the most important symptom with negative impact on HRQL. Sixty-one percent of HCV-infected patients reported
fatigue
-related loss of activity. Additionally, other factors associated with HRQL were gender and histologic cirrhosis. Chronic HCV infection has a profound negative impact on patients' HRQL. Disabling
fatigue
is the most important factor that contributes to loss of well-being in this relatively young group of patients.
...
PMID:Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. 1740 28
The objectives of this study were to describe the quality of life (QOL), consequences of treatment, complementary therapy use, and factors correlating with psychologic state in 58 survivors of early-stage ovarian cancer since little is known about the QOL of early-stage ovarian cancer survivors. Survivors were interviewed using standardized measures to assess physical, psychologic, social, and sexual functioning; impact of cancer on socioeconomic status; and complementary therapy use. Survivors reported good physical QOL scores and few unmet needs. However, menopausal symptoms and negative impact on sexuality were reported. Less than 10% of survivors reported either an interest in sex or were sexually active. Psychologic assessment yielded a subset of 26% of patients with scores suggestive of posttraumatic stress disorder (PTSD) and 40% of survivors scored below the norm on the Mental Health Inventory-17 Survey. One third of patients required treatment for family/personal problems and took antianxiety medications. About 56% of survivors reported fear of cancer recurrence and 59% reported anxiety when their CA125 is tested. Better mental health was significantly related to less
fatigue
(Functional Assessment of Cancer Therapy [FACT]-
fatigue
, r = 0.61, P < 0.0001), less pain (European Organisation for Research and Treatment of Cancer [EORTC], r =-0.54, P < 0.0001), fewer stressful life events (Life Event Scale, r =-0.44, P > 0.001), and greater social support (
MOS
Social Support Survey, r = 0.41, P < 0.01). Early-stage ovarian cancer survivors had few physical complaints and unmet needs, but psychologic distress was evident in a subset of survivors; the majority of survivors reported sexual dysfunction. These results indicate the need for intervention and improved distress screening in the early-stage ovarian cancer population.
...
PMID:Long-term adjustment of early-stage ovarian cancer survivors. 1821 77
The
Fatigue
Symptom Inventory has been used extensively to assess and measure
fatigue
in a number of clinical populations. The purpose of the present study was to further establish its utility by examining its operating characteristics and determining the optimal cutoff score for identifying clinically meaningful
fatigue
. The
MOS
36-Item Short Form Vitality scale, a measure widely used to identify individuals with significant
fatigue
-related disability, was used to determine the sensitivity and specificity of the
Fatigue
Symptom Inventory. Results indicate that a score of 3 or greater on those items assessing
fatigue
in the past week is the optimal cutoff score for identifying clinically meaningful
fatigue
. Individuals who scored at or above the cutoff also reported significantly greater
fatigue
interference, more days of
fatigue
on average, and
fatigue
a greater proportion of each day in the past week. Findings suggest that the
Fatigue
Symptom Inventory can be used to discriminate effectively between individuals with and without clinically meaningful
fatigue
.
...
PMID:Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. 1849 13
Traditional Chinese Medicine practitioners consider that chronic
fatigue
reflects a disharmony and depletion in the supply of qi in the body. Qigong is one of the traditional complementary interventions used to strengthen qi through self-practice, and to manage the state of qi to prevent and cure disease. The aim of this study is to assess whether qigong could be used to manage the symptoms of chronic
fatigue
. Eighteen Caucasian, British female participants were recruited, taught a qigong routine during weekly classes over 6 months, and asked to practice it daily for 15 min. Participants completed the core set of the RAND Medical Outcomes Study questionnaire (RAND
MOS
) and a sleep diary during the 2-week baseline control period, and at 3 and 6 months following the start of the trial. The qigong intervention resulted in significant changes in sleep rate score and in the following subscales of the RAND
MOS
: SF36 Vitality, Sleep Problems, Social Activity, Social Activity Limitation due to Health, Health Distress, Mental Health Index and Psychological Well-being. Qigong seems to improve factors related to chronic
fatigue
such as sleep, pain, mental attitude and general mobility after 3 and 6 months. Qigong's positive effects indicate that it represents a potentially safe method of treatment for chronic fatigued patients. However, we cannot completely discount the possible influence of placebo effects, and more objective clinical measures are needed to reproduce our findings with long-term follow-up in a randomized, controlled study involving a larger number of subjects.
...
PMID:Qigong ameliorates symptoms of chronic fatigue: a pilot uncontrolled study. 1895 97
Palliative care for end-stage renal disease (ESRD) is developing in Hong Kong. This is the first local study to explore the symptom burden and quality of life (QOL) of ESRD patients on chronic dialysis and palliative care. This was a prospective cross-sectional study conducted on ESRD patients in a hospital in Hong Kong from January 2006 to April 2007. Data collected included demographics, socioeconomic status, modified Charlson Comorbidity Index (CCI), prevalence and intensity of 23 ESRD-related symptoms as rated by numerical rating scale (0-10), Brief Pain Inventory and QOL by
MOS
SF-36. A total of 179 ESRD patients completed the study; 45 patients (25.1%) were in the palliative care group and 134 patients (74.9%) in the dialysis group. The palliative care group were older (73.1 +/- 7.1 vs 58.2 +/- 11.4 years, P < 0.001), had marginally higher modified CCI (8.5 +/- 1.9 vs 6.1 +/- 2.4, P = 0.05), had more diabetics (62.2 vs 35.8%, P < 0.001) and were of poorer socioeconomic status than the dialysis group. The mean number of symptoms was 8.2 +/- 3.9 and 9.3 +/- 4.7 in the palliative care and the dialysis group, respectively (P = NS).
Fatigue
, cold aversion, pruritus, lower torso weakness and difficulty sleeping were the five most prevalent symptoms in both groups, and were also among the most intense symptoms. QOL was significantly impaired in both groups. Scores of all QOL domains correlated negatively with the number of symptoms (P < 0.001). Our ESRD patients under palliative care and dialysis had overlapping symptom prevalence and intensity, significant symptom burden and impaired QOL.
...
PMID:Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care. 1915 31
Patients with systemic lupus erythematosus often assess their disease activity differently from their physicians. We studied the factors associated with this discordance. The data provided by 534 systemic lupus erythematosus patients were analyzed. We compared the physician and patient assessments of lupus activity on a visual-assessment scale from the same visit. We collected clinical data and scores from
MOS
36-Item Short-Form Health Survey, Systemic Lupus Erythematosus Quality-of-Life Questionnaire, Rheumatology Attitudes Index, Systemic Lupus Erythematosus Disease Activity Index, and revised Systemic Lupus Activity Measure. Patients tended to score their disease activity higher than do their physicians, when these factors were present: poorer general health assessment, presence of thrombocytopenia, hypertension and urinary sediments, and difficulty in carrying groceries. Physicians tended to score the disease activity higher than do the patients in these circumstances proteinuria, hemolysis, use of azathioprine or cyclophosphamide,
tiredness
, photosensitivity, higher revised Systemic Lupus Activity Measure score, casturia, and patient report of being more easily ill than are other patients. There was only moderate correlation between the discordance in the baseline and the subsequent visits. The physician assessment of disease activity at baseline correlated better with an objective measure of disease activity (revised Systemic Lupus Activity Measure) in the subsequent visit than the patient assessment. In conclusion, discordance in the perception of disease activity between patients and physicians may be amenable to intervention.
...
PMID:Discordant assessment of lupus activity between patients and their physicians: the Singapore experience. 1988 May 53
The purpose of this study was to determine which symptoms are the most reported occur most frequently, have the greatest severity, and cause the most bother for patients on hemodialysis (HD), and to determine if the symptoms experienced differ between the first (HD1) and second (HD2) treatments of the week. An observational, comparative design was used to determine participants' HD symptoms experienced on HD1 and HD2, and the effect of the symptom experience on quality of life (QOL). One hundred subjects were recruited from five dialysis centers. The adapted Dialysis Frequency, Severity, and Symptom Burden Index (DFSSBI) and the Medical Outcomes Study Short Form 36 (
MOS
SF 36) were administered (N = 99) on HD1 and the DFSSBI again on HD2. Data were analyzed for significance among symptom experience test scores in relation to HD1 and HD2, QOL, and gender and age. Of 31 symptoms assessed respondents reported an average of 9.77 symptoms on HD1 and 7.51 symptoms on HD2. Overall, more symptoms were reported and were more frequent, severe, and bothersome on HD1 when the level of metabolic waste is highest. The most reported symptoms included
tiredness
, dry skin, difficulty falling asleep, itching, numbness/tingling, difficulty staying asleep, decreased interest in sex, and bone/joint pain. Females scored consistently higher than males in the four symptom dimensions. Respondents reported about the same as the population norm (50) on the physical component summary score of the
MOS
SF 36 and higher than the norm (65.23) on the mental component summary score. The study found patients on HD experience multiple symptoms that can be frequent, severe, and bothersome. Interventions should be developed and tested to reduce symptom bother and improve QOL.
...
PMID:Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis. 2129 Sep 17
Few studies have examined the quality of life (QOL) in survivors of non-Hodgkin lymphoma (NHL). A total of 109 patients with NHL (58 aggressive [AGG], 51 indolent [IND]) completed two health-related QOL assessments using the Medical Outcomes Study 36-Item Short-Form Healthy Survey (
MOS
SF-36) and the Functional Assessment in Cancer Therapy -
Fatigue
(FACT-F). Scores between IND and AGG were compared using a two-sample t-test. Multiple linear regression was performed to account for any potentially explanatory variables. Overall, 70.6% had received chemotherapy and 55% had received immunotherapy. Some 17.6% of the IND group had received no therapy. The overall physical and mental component QOL scores of the SF-36 did not differ between survivors. Physical function in survivors of IND was significantly better when compared with that of AGG NHL. Our study reports a similar overall QOL between survivors of IND and AGG NHL. Physical function, however, may be more impaired in survivors of AGG NHL.
...
PMID:Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma. 2174 95
Chronic fatigue syndrome (CFS) is characterised by incapacitating
fatigue
in combination with a number of minor criteria, including unrefreshing sleep without further specifications, in the absence of psychiatric and internal disease. As little data exist on subjective sleep quality and daytime sleepiness, these parameters were assessed in a large sample of CFS patients. Consecutive patients with a diagnosis of CFS in a tertiary referral centre filled out the
Fatigue
Questionnaire (FQ), Medical Outcomes Study 36-Item Short Form Health Survey (
MOS
SF-36), Epworth Sleepiness Scale (ESS) and Pittsburgh Sleep Quality Index (PSQI). Inclusion comprised 415 individuals (mean age 40.5 yr, SD 7.9, range 18-64; 86% female). Mean FQ (26.90; SD 4.04), mean Global Physical Health from the
MOS
SF-36 (29.30; SD 12.25) and Global Mental Health from the
MOS
SF-36 (49.62; SD 18.31) scores corresponded with literature data for similar CFS samples. High mean ESS (10.51; SD 5.52) and global PSQI (10.17; SD 4.02) were observed. No significant relationship was found between ESS and global PSQI. In contrast, regression analysis demonstrated a significant cubic relation between ESS and 'PSQI without daytime dysfunction'. A subgroup (n=69) with an insomnia-like phenotype low ESS (<5), high PSQI (mean 11.51; SD 3.86) was observed. The assessment of subjective sleep quality and daytime sleepiness in a large sample of CFS patients indicated high mean PSQI and ESS values. ESS and 'PSQI without daytime dysfunction' were inversely related at the spectral ends of ESS. A distinct subgroup with clinical features of insomnia was identified.
...
PMID:Subjective sleep quality and daytime sleepiness in a large sample of patients with chronic fatigue syndrome (CFS). 2248 34
<< Previous
1
2
3
Next >>